Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide for Peptic Ulcer Prevention in Patients on Dual Antiplatelet Therapy
NCT02166008Phase 3Completed
- Start
- Jul 2014
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in peptic ulcer disease (PUD) comparing Rebamipide with Placebo (2 arms). Primary endpoint: Number of peptic ulcer by endoscopy at 1 year. Started Jul 2014; status: completed.
02
Drugs
rebamipide
03
Conditions
peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT02166008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02166008.